Expression of a functional single chain antibody on the surface of extracellular enveloped vaccinia virus as a step towards selective tumour cell targeting

Journal of General Virology

Volumn 78, Issue 11, 1997, Pages 3019-3027

  Galmiche, Marie C ^a   Rindisbacher, Lorenz ^a   Wels, Winfried ^b   Wittek, Riccardo ^a   Buchegger, Franz ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b TUMOR BIOLOGY CENTER   (Germany)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEMAGGLUTININ; HYBRID PROTEIN; PROTEIN TYROSINE KINASE; TUMOR ANTIGEN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CANCER CELL DESTRUCTION; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; VACCINIA VIRUS; VIRUS ENVELOPE; VIRUS RECOMBINANT;

ANIMALIA; VACCINIA; VACCINIA VIRUS;

EID: 0030783171     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-11-3019     Document Type: Article

References (45)

1. Appleyard, G., Hapel, A. J. & Boulter, E. A. (1971). An antigenic difference between intracellular and extracellular rabbitpox virus. Journal of General Virology 3, 9-17.
2. Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., Rosen, P. P., Twaddell, T., Henderson, I. C. & Norton, L. (1996). Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Journal of Clinical Oncology 14, 737-744.
3. Blasco, R. & Moss, B. (1992). Role of cell-associated enveloped vaccinia virus in cell-to-cell spread [erratum 66, 5703-5704]. Journal of Virology 66, 4170-4179.
4. Bodey, B., Siegel, S. E. & Kaiser, H. E. (1996). Human cancer detection and immunotherapy with conjugated and nonconjugated monoclonal antibodies [Review]. Anticancer Research 16, 661-674.
5. Chang, W., Hsiao, J. C., Chung, C. S. & Bair, C. H. (1995). Isolation of a monoclonal antibody which blocks vaccinia virus infection. Journal of Virology 69, 517-522.
6. Chu, T. H. & Dornburg, R. (1995). Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. Journal of Virology 69, 2659-2663.
7. Han, X., Kasahara, N. & Kan, Y. W. (1995). Ligand-directed retroviral targeting of human breast cancer cells. Proceedings of the National Academy of Sciences, USA 92, 9747-9751.
8. Harwerth, I. M., Wels, W., Marte, B. M. & Hynes, N. E. (1992). Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists. Journal of Biological Chemistry 267, 15160-15167.
9. Hodge, J. W., Abrams, S., Schlom, J. & Kantor, J. A. (1994). Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Research 54, 5552-5555.
10. Hynes, N. E. & Stern, D. F. (1994). The biology of erbB2/neu/HER-2 and its role in cancer. Biochimica et Biophysica Acta 1198, 165-184.
11. Ichihashi, Y. (1996). Extracellular enveloped vaccinia virus escapes neutralization. Virology 217, 478-485.
12. Ichihashi, Y. & Dales, S. (1971). Biogenesis of poxviruses: inter-relationship between hemagglutinin production and polykaryocytosis. Virology 46, 533-543.
13. Ichihashi, Y. & Oie, M. (1996). Neutralizing epitope on penetration protein of vaccinia virus. Virology 220, 491-494.
14. Ichihashi, Y., Matsumoto, S. & Dales, S. (1971). Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology 46, 507-532.
15. Ichihashi, Y., Takahashi, T. & Oie, M. (1994). Identification of a vaccinia virus penetration protein. Virology 202, 834-843.
16. Jin, D. Y., Li, Z. L., Jin, Q., Hao, Y. W. & Hou, Y. D. (1989). Vaccinia virus hemagglutinin. A novel member of the immunoglobulin superfamily. Journal of Experimental Medicine 170, 571-576.
17. Kasahara, N., Dozy, A. M. & Kan, Y. W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions [see comments]. Science 266, 1373-1376.
18. Katz, E., Wolffe, E. J. & Moss, B. (1997). The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. Journal of Virology 71, 3178-3187.
19. Lai, C. F., Gong, S. C. & Esteban, M. (1991). The 32-kilodalton envelope protein of vaccinia virus synthesized in Escherichia coli binds with specificity to cell surfaces. Journal of Virology 65, 499-504.
20. Lee, S. S., Eisenlohr, L. C., McCue, P. A., Mastrangelo, M. J. & Lattime, E. C. (1994). Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors. Cancer Research 54, 3325-3328.
21. Mach, J. P., Pelegrin, A. & Buchegger, F. (1991). Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors [Review]. Current Opinion in Immunology 3, 685-693.
22. Mackett, M., Smith, G. L. & Moss, B. (1982). Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, USA 79, 7415-7419.
23. Marin, M., Noel, D., Valsesiawittman, S., Brockly, F., Etiennejulan, M., Russell, S., Cosset, F. L. & Piechaczyk, M. (1996). Targeted infection of human cells via major histocompatibility complex class I molecules by moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. Journal of Virology 70, 2957-2962.
24. McIntosh, A. A. & Smith, G. L. (1996). Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. Journal of Virology 70, 272-281.
25. Moritz, D., Wels, W., Mattern, J. & Groner, B. (1994). Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB1-expressing tumor cells. Proceedings of the National Academy of Sciences, USA 91, 4318-4322.
26. Panicali, D. & Paoletti, E. (1982). Construction of poxviruses as cloning vectors : insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proceedings of the National Academy of Sciences, USA 79, 4927-4931.
27. Payne, L. G. (1978). Polypeptide composition of extracellular enveloped vaccinia virus. Journal of Virology 27, 28-37.
28. Payne, L. G. (1979). Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. Journal of Virology 31, 147-155.
29. Payne, L. G. (1980). Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. Journal of General Virology 50, 89-100.
30. Payne, L. G. & Kristensson, K. (1985). Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo. Journal of General Virology 66, 643-646.
31. Payne, L. G. & Norrby, E. (1978). Adsorption and penetration of enveloped and naked vaccinia virus particles. Journal of Virology 27, 19-27.
32. Peplinski, G. R., Tsung, K., Meko, J. B. & Norton, J. A. (1995). In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1β. Surgery 118, 185-191.
33. Perkus, M. E., Panicali, D., Mercer, S. & Paoletti, E. (1986). Insertion and deletion mutants of vaccinia virus. Virology 152, 285-297.
34. Sarov, I. & Joklik, W. K. (1972). Studies on the nature and location of the capsid polypeptides of vaccinia virions. Virology 50, 579-592.
35. Seki, M., Oie, M., Ichihashi, Y. & Shida, H. (1990). Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology 175, 372-384.
36. Shida, H. (1986). Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150, 451-462.
37. Shida, H., Tochikura, T., Sato, T., Konno, T., Hirayoshi, K., Seki, M., Ito, Y., Hatanaka, M., Hinuma, Y., Sugimoto, M. and others (1987). Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO Journal 6, 3379-3384.
38. Somia, N. V., Zoppe, M. & Verma, I. M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proceedings of the National Academy of Sciences, USA 92, 7570-7574.
39. Verbik, D. J. & Joshi, S. S. (1995). Immune cells and cytokines - their role in cancer immunotherapy [Review]. International Journal of Oncology 7, 205-223.
40. Wels, W., Harwerth, I. M., Mueller, M., Groner, B. & Hynes, N. E. (1992a). Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Research 52, 6310-6317.
41. Wels, W., Harwerth, I. M., Zwickl, M., Hardman, N., Groner, B. & Hynes, N. E. (1992b). Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Bio/Technology 10, 1128-1132.
42. Wels, W., Beerli, R., Hellmann, P., Schmidt, M., Marte, B. M., Kornilova, E. S., Hekele, A., Mendelsohn, J., Groner, B. & Hynes, N. E. (1995). EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. International Journal of Cancer 60, 137-144.
43. Whitman, E. D., Tsung, K., Paxson, J. & Norton, J. A. (1994). In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy. Surgery 116, 183-188.
44. Wittek, R., Richner, B. & Hiller, G. (1984). Mapping of the genes coding for the two major vaccinia virus core polypeptides. Nucleic Acids Research 12, 4835-4848.
45. Yarden, Y. (1990). Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. Proceedings of the National Academy of Sciences, USA 87, 2569-2573.